Immunobiologic and Antiinflammatory Properties of a Bark Extract from Ampelozizyphus amazonicus Ducke

Abstract EN

Ampelozizyphus amazonicus is used in the treatment and prevention of malaria.

The effect of an aqueous extract from this plant (SART) on the immune response was investigated by measuring immunoglobulin production induced by immunization with the antigen TNP-Ficoll in Plasmodium chabaudi-infected mice.

SART treatment increased antigen-specific IgM and IgG levels in TNP-Ficoll-immunized mice.

The B cell response during malarial infection was also modified by SART.

There was an increase in total serum IgM and IgG and a decrease in the percentage of splenic plasma cells (CD138+ cells) in P.

chabaudi-infected, SART-treated animals.

SART (1, 3 or 10 mg/kg, p.o.) and the reference drug dexamethasone (5 mg/kg) were also tested in carrageenan-induced leukocyte migration to the subcutaneous air pouch (SAP).

All SART doses significantly reduced leukocyte migration into the SAP.

The protein concentration resulting from extravasation into the peritoneum was also significantly reduced.

Our data indicate that SART possesses immunomodulatory properties, inducing an in vivo modification of the B lymphocyte response and anti-inflammatory properties, which are partly due to a reduction in cell migration and are most likely due to an inhibition of the production of inflammatory mediators.

Preliminary HPLC-ESI-MS/MS analysis of SART shows a complex saponin profile with deprotonated molecule [M-H]− ions in the range of m/z 800–1000.